Globus Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 2.67 Cr
- Company Age 27 Year, 8 Months
- Last Filing with ROC 31 Mar 2012
- Open Charges ₹ 23.55 Cr
About Globus Biotech
Globus Biotech Limited (GBL) is a Public Limited Indian Non-Government Company incorporated in India on 29 May 1997 and has a history of 27 years and eight months. Its registered office is in Delhi, India.
The Corporate was formerly known as Gaurav Pharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2012. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.67 Cr.
The company currently has active open charges totaling ₹23.55 Cr.
Krishan Kumar, Sunil Manuja, and Girish Varshey serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232DL1997PLC087583
-
Company No.
087583
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
29 May 1997
-
Date of AGM
29 Sep 2012
-
Date of Balance Sheet
31 Mar 2012
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Globus Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishan Kumar
|
Managing Director | 20-Sep-2003 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sunil Manuja
|
Director | 17-Apr-2009 | Current |
|
Girish Varshey
|
Director | 17-Apr-2009 | Current |
Financial Performance of Globus Biotech.
Enhance accessibility to Globus Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Globus Biotech?
Unlock access to Globus Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹23.55 Cr
₹0
Charges Breakdown by Lending Institutions
- Punjab & Sind Bank : 23.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2005 | Punjab & Sind Bank | ₹9.10 Cr | Open |
| 28 May 2005 | Punjab & Sind Bank | ₹3.80 Cr | Open |
| 19 Oct 2002 | Punjab & Sind Bank | ₹1.00 Cr | Open |
| 19 Oct 2002 | Punjab & Sind Bank | ₹3.50 M | Open |
| 05 May 1999 | Punjab & Sind Bank | ₹1.25 Cr | Open |
How Many Employees Work at Globus Biotech?
Globus Biotech has a workforce of 0 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Globus Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globus Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
